State of Wisconsin Investment Board increased its position in Core Laboratories N.V. (NYSE:CLB) by 12.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 84,320 shares of the oil and gas company’s stock after buying an additional 9,070 shares during the period. State of Wisconsin Investment Board owned about 0.19% of Core Laboratories N.V. worth $8,539,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of CLB. Creative Planning raised its position in shares of Core Laboratories N.V. by 1.9% in the first quarter. Creative Planning now owns 1,730 shares of the oil and gas company’s stock worth $200,000 after buying an additional 33 shares during the last quarter. ProShare Advisors LLC raised its position in shares of Core Laboratories N.V. by 8.5% in the first quarter. ProShare Advisors LLC now owns 3,802 shares of the oil and gas company’s stock worth $439,000 after buying an additional 297 shares during the last quarter. Janney Montgomery Scott LLC raised its position in shares of Core Laboratories N.V. by 42.7% in the first quarter. Janney Montgomery Scott LLC now owns 11,367 shares of the oil and gas company’s stock worth $1,313,000 after buying an additional 3,404 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its position in shares of Core Laboratories N.V. by 21.5% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 3,684 shares of the oil and gas company’s stock worth $425,000 after buying an additional 653 shares during the last quarter. Finally, Parsons Capital Management Inc. RI raised its position in shares of Core Laboratories N.V. by 15.4% in the first quarter. Parsons Capital Management Inc. RI now owns 10,436 shares of the oil and gas company’s stock worth $1,206,000 after buying an additional 1,394 shares during the last quarter.

Core Laboratories N.V. (NYSE:CLB) opened at 89.61 on Friday. The company has a 50-day moving average of $98.61 and a 200 day moving average of $106.75. Core Laboratories N.V. has a one year low of $87.83 and a one year high of $125.83. The company has a market cap of $3.96 billion, a P/E ratio of 54.98 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last posted its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. During the same period last year, the firm posted $0.35 EPS. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts anticipate that Core Laboratories N.V. will post $2.09 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, August 14th. Shareholders of record on Monday, July 17th were issued a dividend of $0.55 per share. The ex-dividend date was Thursday, July 13th. This represents a $2.20 annualized dividend and a yield of 2.46%. Core Laboratories N.V.’s dividend payout ratio (DPR) is currently 134.15%.

ILLEGAL ACTIVITY NOTICE: This report was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://theolympiareport.com/2017/08/27/state-of-wisconsin-investment-board-has-8-54-million-stake-in-core-laboratories-n-v-clb.html.

CLB has been the subject of a number of recent analyst reports. Zacks Investment Research lowered shares of Core Laboratories N.V. from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Credit Suisse Group upgraded shares of Core Laboratories N.V. from a “neutral” rating to an “outperform” rating and set a $110.00 price objective for the company in a report on Thursday. They noted that the move was a valuation call. BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. ValuEngine upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Finally, Morgan Stanley decreased their target price on shares of Core Laboratories N.V. from $130.00 to $125.00 and set an “overweight” rating for the company in a research note on Monday, August 7th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $116.75.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.